HIV patients receiving HAART therapy can still transmit the virus. Highly active antiretroviral chemotherapy
Pomerantz, R.J.
American Family Physician 59(10): 2855
1999
ISSN/ISBN: 0002-838X PMID: 10348077 Document Number: 498596
Document emailed within 1 workday
Related Documents
Da Silva, C.A.L.; Dourado, I.ês.; Dahia, S.R.; Harzheim, E.; Rutherford, G.W. 2008: Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil Journal of Public Health Dentistry 68(3): 178-181Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715s
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Domingos, H.; Cunha, R.V.ân.d.; Paniago, A.M.M.; Martins, D.M.; Elkhoury, E.B.ão.; Souza, A.S.d. 2009: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(2): 130-136
Sharma, M.; Legesse, H. 2016: Parametric Modeling of Survival Data Based on Human Immune Virus (HIV) Infected Adult Patients under Highly Active Antiretroviral Therapy (HAART): a Case of Zewditu Referral Hospital, Addis Ababa (AA), Ethiopia International Journal of Statistics in Medical Research 5(4): 240-247
Leng, L.K.; Pancharoen, C.; Bunupuradah, T.; Thisyakorn, U.; Trinavarat, P.; Sosothikul, D.; Ananworanich, J. 2007: Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease Journal of the Medical Association of Thailand 90(9): 1937-1942
Jáuregui Camargo, L.; Ruiz-Palacios, G.; Guerrero Almeida, L.; Niño Oberto, S.; Peasey, A.; Sierra Madero, J. 2003: Evaluation of highly active antiretroviral therapy (HAART) in a cohort of patients with HIV infection in Mexico Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(1): 10-17
Bedingfield, N.; Kipp, W.; Kaler, A.; Rubaale, T. 2014: Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda Aids Care 26(1): 75-78
Idiculla, J. 2011: Anthropometric changes in patients receiving highly active antiretroviral therapy (ART) Journal of the Association of Physicians of India 59: 530; Author Reply 530
Akinbo, F.O.; Omoregie, R. 2012: Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria Journal of Research in Health Sciences 12(1): 15-18
Hengge, U.R.; Goos, M.; Esser, S.; Exner, V.; Dötterer, H.; Wiehler, H.; Borchard, C.; Müller, K.; Beckmann, A.; Eppner, M.T.; Berger, A.; Fiedler, M. 1998: Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients Aids 12(17): F225-F234
Sevastianova, K.; Sutinen, J.; Westerbacka, J.; Ristola, M.; Yki-Järvinen, H. 2005: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy Antiviral Therapy 10(8): 925-935
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Breuckmann, F.; Neumann, T.; Kondratieva, J.; Wieneke, H.; Ross, B.; Nassenstein, K.; Barkhausen, J.; Kreuter, A.; Brockmeyer, N.; Erbel, R. 2005: Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART) European Journal of Medical Research 10(9): 395-399
Edlin, B.R. 1999: Change of HAART. Highly active antiretroviral therapy Lancet 353(9167): 1888
Bwana, V.; Tenu, F.; Magesa, S.M.; Mfinanga, S.G. 2011: Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania Tanzania Journal of Health Research 13(1): 14-20
Girardi, E.; Sabin, C.A.; d'Arminio Monforte, A.; Hogg, B.; Phillips, A.N.; Gill, M.John.; Dabis, F.; Reiss, P.; Kirk, O.; Bernasconi, E.; Grabar, S.; Justice, A.; Staszewski, S.; Fätkenheuer, G.; Sterne, J.A.C. 2005: Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(12): 1772-1782
Nelwan, E.J. 2014: Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient Acta Medica Indonesiana 46(4): 273-274